FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Helle Anita Jensen

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Esophagogastric Junction

Co-author Network

Publications

TOP 3
Lene W Vestermark; Helle Anita Jensen; Per Pfeiffer
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Maria Andersen; Katrine R Schønnemann; Mette Yilmaz; Helle Anita Jensen; Lene W Vestermark; Per Pfeiffer
Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.
Jon K Bjerregaard; Michael Bau Mortensen; Helle Anita Jensen; Claus Wilki Fristrup; Birgitte Svolgaard; Katrine R Schønnemann; Tine P Hansen; Morten Nielsen; Jørgen Johansen; Per Pfeiffer
Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Helle Anita Jensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lene W Vestermark; Helle Anita Jensen; Per Pfeiffer
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Acta oncologica (Stockholm, Sweden) 2012;51(3):311-7.
2010: Maria Andersen; Katrine R Schønnemann; Mette Yilmaz; Helle Anita Jensen; Lene W Vestermark; Per Pfeiffer
Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.
Acta oncologica (Stockholm, Sweden) 2010;49(8):1246-52.
2009: Jon K Bjerregaard; Michael Bau Mortensen; Helle Anita Jensen; Claus Wilki Fristrup; Birgitte Svolgaard; Katrine R Schønnemann; Tine P Hansen; Morten Nielsen; Jørgen Johansen; Per Pfeiffer
Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(2):226-30.
2008: K R Schønnemann; Helle Anita Jensen; M Yilmaz; B Y Jensen; O Larsen; Per Pfeiffer
Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.
British journal of cancer 2008;99(6):858-61.
2008: Helle Anita Jensen; Henning Overgaard Nielsen; Jeanette Dupont Jensen; Claus Wilki Fristrup; Morten Nielsen; Per Pfeiffer
[Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Ugeskrift for laeger 2008;170(8):639-41.
2007: Jeanette Dupont; Helle Anita Jensen; Benny Vittrup Jensen; Per Pfeiffer
Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(3):330-5.
2006: Per Pfeiffer; Gunnar Baatrup; Helle Anita Jensen; Ole Kronborg
[New treatment strategies for patients with primary non-resectable rectal cancer].
Ugeskrift for laeger 2006;168(19):1857-60.
2006: Gunnar Baatrup; P Pfeiffer; Birgitte Svolgaard; Helle Anita Jensen
Resectability of rectal cancers still fixed after radio-chemotherapy: evaluation by digital rectal examination, MRI, and intraoperative examination.
International journal of colorectal disease 2006;21(1):7-10.
2005: SM de Lange; Kasper van der Born; Judith R Kroep; Helle Anita Jensen; P Pfeiffer; A Cleverly; Cees J van Groeningen; Godefridus J Peters
No evidence of gemcitabine accumulation during weekly administration.
European journal of clinical pharmacology 2005;61(11):843-9.
2003: Per Pfeiffer; Pernille Hahn; Helle Anita Jensen
Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(8):832-6.
1999: Dorthe Ejersbo; Helle Anita Jensen; Berit Hølund
Efficacy of Ki-67 antigen staining in Papanicolaou (Pap) smears in post-menopausal women with atypia--an audit.
Cytopathology : official journal of the British Society for Clinical Cytology 1999;10(6):369-74.